GOLD Learning Speakers
Jim Thigpen, PharmD, BCPS
- Speaker Type: Pharmacology Lecture Pack 2017, Pain Management in the NICU Lecture Pack 2019, Advancements in Neonatal Pharmacology Lecture Pack 2023
- Country: USA
Biography:
Jim Thigpen has been a pediatric clinical pharmacist for 30 years and is currently an associate professor of pharmacy at East Tennessee State University Bill Gatton College of Pharmacy. When he began his training at MUSC in Charleston, SC, they were investigating Survanta and he has been witness to and a participant in the evolving world of neonatology since. He has spoken at several neonatal nursing conferences over the years and enjoys helping other practitioners learn about and apply pharmacotherapy in this special population.
CE Library Presentation(s) Available Online:
Choosing wisely – Antibiotic Selection in the NICU
When faced with a potential neonatal infection, it is critical to choose the correct antibiotic(s) for the situation. Considering the environment of antibiotic resistance and some of the limitations for antibiotic use in this fragile population, selecting the right drug, dose, interval and monitoring parameters can be life and death decisions. This presentation will help the learner understand the complexities of this problem and provide them with the tools to provide state-of-the-art medical care.
Presentations:
6 | Hours / CE Credits: 6
| Viewing Time: 4 Weeks
Hours / CE Credits: 1 (details) | Categories:
(IBCLC) Infant, (IBCLC) Infant, Antibiotic Use in the NICU
Clinical Pain Management in the Neonate
Managing pain and discomfort in the neonatal patient is complex in many ways. Immature metabolic processes can lead to unpredictable effects that may lead to either negative effects and/or unsuccessful control of pain. As we have learned more about these metabolic pathways and how these medications are utilized, more evidence now exists that determine when one medication may be preferred over another depending on the clinical situation. Looking into the future of drug dosing, we may soon be able to determine a neonate's pharmacogenomic profile in order to provide true personalized medicine.
This presentation will help the learner understand the complexities of these challenges and provide them with the information and the tools to provide state-of-the-art medical care.
Presentations:
5 | Hours / CE Credits: 5
| Viewing Time: 4 Weeks
Hours / CE Credits: 1 (details) | Categories:
Pain Management in the NICU
Pharmacotherapy for Hemodynamic Instability in Neonates
There are many causes of hemodynamic instability in the neonate, with up to half of very low birth weight (VLBW) infants exhibiting evidence of low cardiac output and poor myocardial contractility within the first 12 hours of life. Failure to appropriately identify and address the causes of hypotension can lead to dramatic consequences in this vulnerable population. Pharmacotherapy is employed to provide action at specific receptors that result in improved cardiac output, relaxation and vasodilation of smooth muscle, as well as specific effects on the kidneys. Although the common agents have been used for decades, there are new developments in therapy. Refinements on patient selection, managing expected side effects, and effective dosing and have continued to evolve.
Presentations:
6 | Hours / CE Credits: 6
| Viewing Time: 4 Weeks
Hours / CE Credits: 1 (details) | Categories:
(IBCLC) Pharmacology and Toxicology, Pharmacology in the NICU
